European Archives - Page 866 of 1616 - European Medical Journal

Review of the European Society of Cardiology (ESC) Congress 2023

The European Society of Cardiology (ESC) inaugural session unfolded against the backdrop of Amsterdam, the Netherlands…

Sex-Based Differences in Short-Term Survival Following Out-of-Hospital Cardiac Arrest

Out-of-hospital cardiac arrest (OHCA) is the most common cause of cardiac-related death, and continues to be a public health burden with…

Editor’s Pick: Obstructive Sleep Apnoea as an Exacerbator of Vasospastic Angina

Little is known about the association between obstructive sleep apnoea (OSA) and vasospastic angina. The authors report the case of a…

2023 European Society of Cardiology (ESC) Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes

Patients with diabetes have an increased risk of CVD. The presence of two comorbidities, diabetes and CVD, can have a major…

Characterisation of Patients with Acute Coronary Syndrome: A 10-Year Experience

Coronary intervention is a therapeutic method for acute coronary syndrome. Characterise patients with acute coronary syndrome treated…

Adult Survivors of Childhood Cancer Have Significant Levels of Impaired Cardiorespiratory Fitness, Inflammatory Markers, and Poor Quality of Life Outcomes

Almost two-thirds of the 35,000 children diagnosed with cancer in Europe each year are treated with anthracycline chemotherapy. Despite…

Artificial Intelligence and Heart Failure

To emphasise the importance of this topic, Oguz Akbilgic, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA…

Risk Factors and Patterns of Myocardial Injury in Patients with COVID-19: A Single-Centre Cohort Study

The primary objective was to compare the risk factors and trends of patients with COVID-19 with and without biochemical evidence of…

ESC 2023 Abstract Highlights

The following selected highlights showcase intriguing and relevant abstracts presented at the European Society of Cardiology (ESC)…

PCSK9 Targeting in the Management of Hypercholesterolaemia

In the current era of optimal risk factor modification, proprotein convertase subtilisin/kexin type 9 (PCSK9) targeting has emerged as a…